Valuation: NIOX Group Plc

Market Cap 276M 366M 321M 303M 517M 35.04B 521M 3.63B 1.4B 17.9B 1.37B 1.34B 57.53B P/E 2026 *
29.8x
P/E 2027 * 25.1x
Enterprise Value 248M 329M 289M 273M 465M 31.52B 468M 3.26B 1.26B 16.11B 1.23B 1.21B 51.76B EV / Sales 2026 *
4.93x
EV / Sales 2027 * 4.37x
Free-Float
79.07%
Yield 2026 *
2.6%
Yield 2027 * 2.94%
1 day-3.24%
1 week-2.38%
Current month-3.53%
1 month-1.50%
3 months+18.84%
6 months+9.33%
Current year-1.20%
1 week 65
Extreme 65
69
1 month 65
Extreme 65
69
Current year 53.84
Extreme 53.84
72
1 year 53.84
Extreme 53.84
76
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 15/01/2025
Director of Finance/CFO - 13/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 07/02/2018
Director/Board Member - 01/09/2019
Chairman 73 04/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Buy

Chief Financial Officer

34,127 0.0081%
29/05/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/05/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
-3.24%-2.38%-10.38%-6.82% 366M
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average -0.00%+0.43%+26.58%+43.04% 363.87B
Weighted average by Cap. +0.02%+1.32%+41.53%+67.82%

Financials

2026 *2027 *
Net sales 50.36M 66.68M 58.51M 55.26M 94.28M 6.39B 94.95M 661M 256M 3.27B 250M 245M 10.49B 54.24M 71.82M 63.02M 59.52M 102M 6.88B 102M 712M 276M 3.52B 270M 264M 11.3B
Net income 10.99M 14.55M 12.77M 12.06M 20.57M 1.39B 20.72M 144M 55.88M 712M 54.62M 53.44M 2.29B 12.76M 16.9M 14.83M 14.01M 23.89M 1.62B 24.06M 168M 64.92M 828M 63.45M 62.08M 2.66B
Net Debt -27.67M -36.64M -32.15M -30.37M -51.81M -3.51B -52.18M -363M -141M -1.79B -138M -135M -5.77B -38.99M -51.63M -45.3M -42.79M -72.99M -4.95B -73.51M -512M -198M -2.53B -194M -190M -8.12B
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
25/09/26 GBX 65.60 -3.24% 453,878
24/09/26 GBX 67.80 +0.30% 627,670
23/09/26 GBX 67.60 +0.90% 817,972
22/09/26 GBX 67.00 0.00% 509,973
21/09/26 GBX 67.00 -0.30% 286,269
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6560GBP
Average target price
0.8150GBP
Spread / Average Target
+24.24%

Annual profits - Rate of surprise